<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from the
Form 10-QSB of Gish Biomedical, Inc., for the three months ended September 30,
2000 and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<CIK> 0000700945
<NAME> GISH BIOMEDICAL, INC.
<MULTIPLIER> 1000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 461
<SECURITIES> 685
<RECEIVABLES> 3,329
<ALLOWANCES> 171
<INVENTORY> 8,040
<CURRENT-ASSETS> 12,426
<PP&E> 9,673
<DEPRECIATION> 7,512
<TOTAL-ASSETS> 14,742
<CURRENT-LIABILITIES> 1,745
<BONDS> 0
0
0
<COMMON> 10,532
<OTHER-SE> 2,234
<TOTAL-LIABILITY-AND-EQUITY> 14,742
<SALES> 4,285
<TOTAL-REVENUES> 4,285
<CGS> 3,132
<TOTAL-COSTS> 1,704
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (51)
<INCOME-PRETAX> (500)
<INCOME-TAX> 0
<INCOME-CONTINUING> (500)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (500)
<EPS-BASIC> (.14)
<EPS-DILUTED> (.14)
</TABLE>